Biofficient Successfully Launches "Match.com" for Biotech Industry at DIA 2013
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Biofficient.com, the company’s website which hosts the platform, offers a streamlined solution to the arduous process of matching clinical trial sponsors’ specific needs with a comprehensive database of contract services provided by a global list of industry vendors. Completely secure and confidential, sponsors are able to create and send their RFPs to the vendors they select from a list generated by Biofficient’s adaptive matching algorithms.
On the other side of the process, Biofficient opens doors to new business for thousands of vendors that may otherwise not have been aware of valuable projects within their realm of expertise. By building out their free vendor profile on Biofficient’s easy-to-navigate site, qualified companies become a visible, viable contender for business in a highly competitive marketplace.
“We saw an opportunity to greatly improve the inefficiencies on both sides of the biopharmaceutical RFP process, and built out a solution that is beneficial to both the trial sponsors and contract service vendors. In a market that is increasingly relying on outsourced work, a faster, simpler, more cost-efficient way of bringing both parties together and improving the quality of the entire experience as a whole is critical,” said Biofficient CEO Bret Siarkowski..
For more information about Biofficient, or to register for their platform, visit
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025